SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Advanced materials able to withstand extreme environments are the focus of a new binational institute inaugurated May 24.
La Jolla’s Innovus Pharmaceuticals Inc., a commercial-stage drug company that makes over-the-counter medicine, has acquired Austin, Texas-based Beyond Human for $630,000 in cash.
San Diego skin care firm MDRejuvena Inc. has appointed Randy Kriech as president and CEO of the company.
San Diego-based Mesa Biotech Inc., a privately held, molecular diagnostic company, announced the appointment of Tom Willardson as chief financial officer and John Monroe as senior vice president of operations.
These are uneasy days for biotech CFOs. Valuations are down, capital is harder to come by, and companies (fearful they will be undervalued) are shying away from acquisition talks.
One of San Diego County’s biggest drugmakers is teaming up with a cancer center in Texas to tackle new strategies in oncology.
San Diego-based OncoSec Medical Inc. will sell about $10 million of its common stock to a single health care institutional fund, the company announced Monday.
Avalon Ventures is launching yet another startup out of its VC incubator in La Jolla. The firm, called PDI Therapeutics Inc., is jointly backed by British drugmaker GlaxoSmithKline and San Diego’s Avalon as part of an ongoing partnership.
Bioinformatics firm Edico Genome Corp. has landed its third foundational patent, the company announced Thursday. The patent further secures the company’s core technology, and may ease the minds of collaborators considering new applications for the tech.
San Diego-based Ron’s Pharmacy Services has joined forces with Atlanta-based Guardian Pharmacy to streamline certain efforts.
Penny stock Innovus Pharmaceuticals Inc. announced plans Wednesday to uplist to the NYSE MKT, formerly known as the American Stock Exchange.
San Diego’s Fate Therapeutics Inc. has appointed a new chief medical officer in charge of clinical trial design and execution, the company announced Tuesday.
UC San Diego is joining a multimillion-dollar research effort to better understand “microbiomes,” the White House announced. The area of science is a potential goldmine for drug discoveries, and collaborators hope advancing the research will have wide applications in human health.
Venture capital dipped slightly for San Diego companies, according to a first-quarter report from Cushman & Wakefield. The health care sectors, however, are still stealing the show.